Amount Raised
$37.1 Million
Round Type
Post-IPO Equity
WalthamBiotechnologyHealth CareTherapeuticsInvestors
Description
On February 11, 2026, Xilio Therapeutics, Inc. entered into an underwriting agreement for an underwritten offering of pre-funded warrants. The offering allows for the purchase of up to 74,780,300 shares of common stock. The estimated net proceeds from the offering are approximately $37.1 million after deducting expenses.
Quick answer
Xilio Therapeutics raised $37.1 Million in a Post-IPO Equity round, dated February 12, 2026. Investors: Leerink Partners LLC. Xilio Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Xilio Therapeutics raise?
- Xilio Therapeutics raised $37.1 Million in a Post-IPO Equity round on February 12, 2026.
- Who invested in Xilio Therapeutics?
- Leerink Partners LLC is named as investors in this round.
- What does Xilio Therapeutics do?
- Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer.
- Where is Xilio Therapeutics based and how big is it?
- Xilio Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 88 employees.
- Who are the decision-makers at Xilio Therapeutics?
- Fundz holds 1 contact at Xilio Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Xilio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
- Pinnacle Medicines raised $89M (Series B) on March 26, 2026.
- RyboDyn raised $10M (Seed) on March 24, 2026.
- Oryon Cell Therapies raised $21M (Series A) on March 23, 2026.
- Diamyd Medical raised $125M (Funding Round) on March 23, 2026.
- Amani Therapeutics raised $25M (Series A) on March 23, 2026.
Who to call at Xilio Therapeutics, and when
A new round usually means Xilio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Xilio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xilio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xilio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xilio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Xilio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.